Therapeutic effects of intracarotid infusion of spermine/nitric oxide complex on cerebral vasospasm
- PMID: 12376774
- DOI: 10.1007/s00701-002-0971-0
Therapeutic effects of intracarotid infusion of spermine/nitric oxide complex on cerebral vasospasm
Abstract
Background: Vasospasm is one of the underlying causes of morbidity and mortality in subarachnoid haemorrhage (SAH). The therapeutic effects of intracarotid infusion of spermine/nitric oxide complex (SPER/NO) on cerebral vasospasm in an experimental model of SAH were investigated.
Method: Twenty-four adult male New Zealand white rabbits (2.6-3.4 kg in weight) were randomly divided into four groups (n=6), as follows: (I) control group (without SAH and drug), (II) SAH alone group (with SAH, without drug), (III) SAH placebo group (with SAH and saline), and (IV) SAH-SPER/NO group (with SAH and SPER/NO). The fresh autologous non-heparinized blood was injected into the cisterna magna to induce a SAH, after 24 hour SAH, the substance (saline or SPER/NO) was delivered to animals. All rabbits were scarified at 48-hours of induced SAH. The basilar artery with surrounding tissue was removed from the cranium and processed for paraffin embedding. Histopathological and stereological examinations of the basilar artery were done.
Findings: In the SPER/NO treated group of rabbits, the histopathological changes were less severe than in the SAH-alone and SAH-placebo groups. Regarding the intracarotid pressure, there was a statistically significant difference between SAH-alone and SAH-SPER/NO groups and also between SAH-SPER/NO and control groups (p<0.05). The mean cross sectional area of basilar arteries was 0.26 mm(2) in the control, whereas in SAH alone, placebo and SAH-SPER/NO groups were 0.13, 0.15 and 0.20 mm(2), respectively.
Interpretation: It is well known that NO is a critical substance involved in cerebral vascular dynamics. Present results indicate that treatment of vasospasm with SPER/NO in SAH may be promising. However, further studies should be done on this substance to clarify its effect on vasospasm before using the drug in clinical situations.
Similar articles
-
Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage.Acta Neurochir (Wien). 2007 Oct;149(10):1041-7; discussion 1047-8. doi: 10.1007/s00701-007-1275-1. Epub 2007 Sep 17. Acta Neurochir (Wien). 2007. PMID: 17876498
-
Effects of raloxifene on cerebral vasospasm after experimental Subarachnoid Hemorrhage in rabbits.Surg Neurol. 2009 Nov;72(5):490-4; discussion 494-5. doi: 10.1016/j.surneu.2008.11.007. Epub 2009 Jan 14. Surg Neurol. 2009. PMID: 19147193
-
Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.Exp Biol Med (Maywood). 2006 Jun;231(6):1069-74. Exp Biol Med (Maywood). 2006. PMID: 16741051
-
Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.Neurosurgery. 1998 Dec;43(6):1409-17; discussion 1417-8. Neurosurgery. 1998. PMID: 9848855 Review.
-
In vivo animal models of cerebral vasospasm: a review.Neurosurgery. 2000 Feb;46(2):448-60; discussion 460-1. Neurosurgery. 2000. PMID: 10690735 Review.
Cited by
-
Neuroprotective effects of methylprednisolone and hypothermia after experimental spinal cord injury: a histopathological and stereological study.Eurasian J Med. 2009 Dec;41(3):169-74. Eurasian J Med. 2009. PMID: 25610097 Free PMC article.
-
Stereological Evaluation of Tumor Regression Rates in Lung Cancer Using CT Via the Cavalieri Method.Eurasian J Med. 2008 Dec;40(3):109-14. Eurasian J Med. 2008. PMID: 25610042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources